TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD · Healthcare · Market cap $47.3B
Insiders sold $17.0M net in the last 90 days ·8 sellers, 0 buyers· 3 of 8 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 22, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$113.3M
reported sales (SEC code S)
Unique Insiders
14
in the rolling window
Latest filing
Sep 22, 2026
MIGNONE ROBERTO
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) has 65 SEC Form 4 filings (117 transaction rows) in the rolling window, disclosed by 14 distinct insiders. Most recent filing: Sep 22, 2026.
Inside the rolling window, 14 insiders at TEVA PHARMACEUTICAL INDUSTRIES LTD reported no open-market purchases and 46 open-market sales totaling $113.3M. The most active filer is President and CEO Francis Richard D with 5 filings. Insiders have net sold $35.9M over the trailing 6 months. The most recent open-market filing is a sale of 367,600 shares by Director MIGNONE ROBERTO, dated Sep 18, 2026, worth $14.4M.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Richard D. Francis
- Employees:32,008
- HQ:Tel Aviv, TA, IL
- IPO:1982-02-16
| Source | |||||||
|---|---|---|---|---|---|---|---|
MIGNONE ROBERTOFirst in 9 months | Director | Sale | 367,600 | $14.4M | Sep 22 | +2.8% | SEC ↗ |
Savage BrianFirst in 7 months | Interim Chief Legal Officer | Sale | 7,342 | $285K | Sep 22 | +2.8% | SEC ↗ |
Weiss AmirFirst in 4 months | Chief Accounting Officer | Sale | 9,445 | $355K | Aug 25 | +6.6% | SEC ↗ |
Satchi-Fainaro RonitFirst filing | Director | Sale | 415 | $15K | Aug 25 | +6.6% | SEC ↗ |
Lippman EvanFirst in 3 months | EVP, Business Development | Sale | 18,600 | $680K | Aug 19 | +8.4% | SEC ↗ |
Zaks Tal ZviFirst filing | Director | Sale | 17 | $593 | Aug 10 | +12.4% | SEC ↗ |
Hughes Eric AFirst in 5 months | See "Remarks" | Sale | 25,578 | $892K | Aug 5 | +17.0% | SEC ↗ |
Jover PlacidFirst in 5 months | See "Remarks" | Sale | 12,827 | $447K | Aug 5 | — | SEC ↗ |
| EVP, Global Operations | Sale | 9,989 | $322K | Jun 22 | — | SEC ↗ | |
| EVP, Chief Financial Officer | Sale | 106,563 | $3.6M | Jun 16 | — | SEC ↗ | |
Francis Richard DFirst in 3 months | President and CEO | Sale | 6,153 | $211K | Jun 8 | — | SEC ↗ |
| EVP, Global Operations | Sale | 16,195 | $532K | Jun 4 | — | SEC ↗ | |
Lippman EvanFirst filing | EVP, Business Development | Sale | 41,658 | $1.5M | May 18 | — | SEC ↗ |
| EVP, Chief Financial Officer | Sale | 153,251 | $5.5M | May 18 | — | SEC ↗ | |
| EVP, Europe Commercial | Sale | 30,000 | $1.1M | May 7 | — | SEC ↗ | |
Weiss AmirFirst in 5 months | Chief Accounting Officer | Sale | 10,679 | $384K | May 7 | — | SEC ↗ |
| See "Remarks" | Sale | 144,180 | $5.0M | May 4 | — | SEC ↗ | |
| EVP, U.S. Commercial | Sale | 21,258 | $751K | May 4 | — | SEC ↗ | |
Sabag MarkFirst in 3 months | See "Remarks" | Sale | 62,102 | $1.9M | Mar 19 | — | SEC ↗ |
| EVP, Europe Commercial | Sale | 17,295 | $548K | Mar 9 | — | SEC ↗ | |
Shields MatthewFirst filing | EVP, Global Operations | Sale | 17,295 | $548K | Mar 9 | — | SEC ↗ |
| See "Remarks" | Sale | 9,533 | $302K | Mar 9 | — | SEC ↗ | |
Jover PlacidFirst filing | See "Remarks" | Sale | 14,150 | $448K | Mar 9 | — | SEC ↗ |
| President and CEO | Sale | 20,025 | $634K | Mar 9 | — | SEC ↗ | |
| Interim Chief Legal Officer | Sale | 1,127 | $36K | Mar 9 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading TEVA 4 all-time
- RRep. Greg GianfortePurchase$15,001 - $50,0002020-11-13
- DRep. Donna ShalalaOther$1,001 - $15,0002020-05-07
- DRep. David Eugene PriceOther$1,001 - $15,0002019-06-19
- ISen. Angus Stanley KingOther$1,001 - $15,0002016-10-19
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does TEVA have?
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) has 65 SEC Form 4 filings (117 transaction rows) in the rolling 365-day window, disclosed by 14 distinct insiders. Most recent filing: Sep 22, 2026.
When was the most recent SEC Form 4 filing for TEVA?
The most recent Form 4 filing for TEVA on Tracefour is dated Sep 22, 2026.
Who is the most active insider at TEVA?
The most active SEC Form 4 filer at TEVA in the rolling window is President and CEO Francis Richard D, with 5 filings.
What is the net insider flow at TEVA over the last 6 months?
Over the trailing 180 days, insiders at TEVA have net sold $35.9M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at TEVA in the current window?
Inside the rolling window, insiders at TEVA bought $0 and sold $113.3M based on SEC Form 4 filings.
Can I get alerts for TEVA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
TEVA PHARMACEUTICAL INDUSTRIES LTD is in the Healthcare sector.